Inventor · disambiguated record
Weiwei Mao
Also filed as: MAO WEIWEI
7 granted patents·1 pending application·3 citations·filing 2016–2021
71Inventor score
Files withWUXI FORTUNE PHARMACEUTICAL CO LTD4ZHUHAI UNITED LABORATORIES CO LTD3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1
Top patents by PatentIndex Score
8 records- 0180US11919896B2[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 5, 2024·2 cites·19 claims
- 0264US10174056B2Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 8, 2019·1 cites·20 claims
- 0360US12486266B2Crystalline form of JAK inhibitor and application thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2021·Granted Dec 2, 2025·0 cites·13 claims
- 0452US11427581B2JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Aug 30, 2022·0 cites·12 claims
- 0552US2023017539A1Tri-heterocyclic compound as jak inhibitor, and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
- 0649US10774094B2Crystal forms and salt forms of 7h-pyrrolo[2,3-d]pyrimidine compounds and preparation method thereofWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·10 claims
- 0741US10617690B2JAK inhibitorWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Apr 14, 2020·0 cites·27 claims
- 0836US10174036B2Substituted pyrazoles as JAK inhibitorsWUXI FORTUNE PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 8, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Weiwei Mao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →